Statistics
Publications
6
Citations
223
H-Index
6
Active since
2015
Affiliations
Ying Shu is an author at Wuhan University specializing in medicine, molecular oncology, and oncology.
Publications per year
2015–2019
6
6
Allicin inhibits human renal clear cell carcinoma progression via suppressing HIF pathway.
Bin Song, Ying Shu, Tianlei Cui et al. · PubMed · 2015 · 30 citations
Medicine, Oncology, Pharmacology +17
1–5 of 6